June 30, 2026
ESTEVE’S EXPANSION AND GROWTH IN EU AND USA ACCELERATES ITS TRANSFORMATION INTO A GLOBAL HEALTHCARE COMPANY
B New assets in both businesses – Pharma and CDMO – fuel double-digit growth in net revenues and EBITDA and prove strong strategy execution Targeted…
